Antipyretic analgesics inhibit prostaglandin release from astrocytes and macrophages similarly

Eur J Pharmacol. 1986 Oct 14;130(1-2):105-9. doi: 10.1016/0014-2999(86)90188-3.

Abstract

The effect of acid and non-acid antipyretic analgesics on prostaglandin (PG) release from cultured mouse astrocytes and peritoneal macrophages was investigated in order to test the hypothesis that the non-acid compounds are more potent inhibitors of PG formation in brain than in peripheral tissues. Stimulation of the cells by the divalent cation ionophore A 23187 (10(-6) mol/l) induced PG release from astrocytes and macrophages (mainly PGD2 and PGE2, respectively). This PG release was inhibited by acetylsalicylic acid (10(-5) - 10(-6) mol/l) and indomethacin (10(-6) - 10(-9) mol/l) but also by high concentrations (10(-3) - 10(-5) mol/l) of the non-acid compounds 4-methyl-aminophenazone, the main active metabolite of dipyrone (metamizol), and acetaminophen (paracetamol). No difference was found in the inhibitory potency of the drugs in astrocytes and macrophages, suggesting that a specific sensitivity of brain cells toward non-acid antipyretic analgesics does not contribute to their analgesic effect.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Calcimycin / pharmacology
  • Cells, Cultured
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Mice
  • Prostaglandin Antagonists*
  • Radioimmunoassay

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Prostaglandin Antagonists
  • Calcimycin